Nisha Pharmaceuticals Pvt Ltd
About Nisha Pharmaceuticals Pvt Ltd
Data last updated:
Nisha Pharmaceuticals Pvt Ltd is a private limited company based in Mumbai, Maharashtra, India. It operates in the diversified financial services segment of the financial services sector. It was incorporated on 26 July 1983 and has been in existence for over 43 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1983PTC030495.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Nili Jagat Shah and Shaili Jagat Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Das Chamberrs 4th Floor 25 Dalal Street Fort, Mumbai, Maharashtra, India – 400001.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.86 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹4.84 Lakh (net margin -99.6%) and EBITDA of -₹3.43 Lakh (EBITDA margin -70.5%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressDas Chamberrs 4th Floor 25 Dalal Street Fort, Mumbai, Maharashtra, India – 400001
- IndustryFinancial Services, Diversified Financial Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Nisha Pharmaceuticals Pvt Ltd FY 2025 filings available
Nisha Pharmaceuticals Pvt Ltd reported revenue of ₹4.86 Lakh (up 313% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Nisha Pharmaceuticals Pvt Ltd
Revenue has grown at a compounded annual rate (CAGR) of 16% over three years, including 313% growth in the latest year. EBITDA rose 63% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nisha Pharmaceuticals Pvt Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹3.43 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹4.84 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nisha Pharmaceuticals Pvt Ltd
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -70.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -99.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nisha Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Nisha Pharmaceuticals Pvt Ltd
Nisha Pharmaceuticals has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nili Jagat Shah | Director | 28 Nov 2017 | 8 Years 10 Months | Current |
| Shaili Jagat Shah | Director | 28 Nov 2017 | 8 Years 10 Months | Current |
| Nisha Jagat Shah Also directs: River Wellness Bodyshop LLP | Director | 11 Aug 1983 | 43 Years 2 Months | Current |
Peer Comparison of Nisha Pharmaceuticals Pvt Ltd
Nisha Pharmaceuticals Pvt Ltd is compared with the companies closest to it by revenue in the BFSI industry (Other Financial Services, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anjumankhuddamul Mutual Benefit Nidhi Limited | ₹4.87 Lakh (FY 2024) | •••• | •••• | -39.0% | •••• | Bulandshahar, Uttar Pradesh, India |
| Fosto Pharmaceuticals Private Limited | ₹4.87 Lakh (FY 2025) | •••• | •••• | 44.0% | •••• | Bareilly, Uttar Pradesh, India |
| Drugsmith Pharmaceuticals Private Limited | ₹4.87 Lakh (FY 2021) | •••• | •••• | •••• | Ghaziabad, Uttar Pradesh, India | |
| D V Exports Private Limited | ₹4.86 Lakh (FY 2018) | •••• | •••• | 12.0% | •••• | New Delhi, Delhi, India |
| Virat Finlease and Securities Private Limited | ₹4.86 Lakh (FY 2018) | •••• | •••• | 10.0% | •••• | Delhi, India |
| Nisha Pharmaceuticals Pvt Ltd this company | ₹4.86 Lakh (FY 2025) | •••• | •••• | 313.0% | •••• | Mumbai, Maharashtra, India |
| Bluechip Dealers Private Limited | ₹4.86 Lakh (FY 2024) | •••• | •••• | -31.0% | •••• | Kolkata, West Bengal, India |
| Priyanka Holdings Pvt Ltd | ₹4.85 Lakh (FY 2024) | •••• | •••• | 4.0% | •••• | Kolkata, West Bengal, India |
| Medicharge Pharmaceuticals Private Limited | ₹4.85 Lakh (FY 2024) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Shashank Traders Limited Listed | ₹4.84 Lakh (FY 2025) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Authentic Dealcom Private Limited | ₹4.84 Lakh (FY 2025) | •••• | •••• | 28.0% | •••• | Howrah, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Nisha Pharmaceuticals by revenue in the BFSI industry (Other Financial Services, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Nisha Pharmaceuticals Pvt Ltd
Nisha Pharmaceuticals Pvt Ltd is audited by A S MADON & CO for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A S MADON & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Nisha Pharmaceuticals Pvt Ltd
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nisha Pharmaceuticals Pvt Ltd
Nisha Pharmaceuticals Pvt Ltd does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Nisha Pharmaceuticals Pvt Ltd
Employment history and EPFO contributions of people linked to Nisha Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nisha Pharmaceuticals Pvt Ltd
Nisha Pharmaceuticals Pvt Ltd has 6 board changes on record since 1983: 3 appointments and 3 cessations. The latest: Nili Jagat Shah ceased to be Additional Director on 28 Sep 2018.
Credit Ratings, Litigation & Regulatory Alerts for Nisha Pharmaceuticals Pvt Ltd
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nisha Pharmaceuticals Pvt Ltd
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nisha Pharmaceuticals Pvt Ltd
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nisha Pharmaceuticals Pvt Ltd
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nisha Pharmaceuticals Pvt Ltd
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nisha Pharmaceuticals Pvt Ltd
Nisha Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in diversified financial services, within the financial services industry. It was incorporated on 26 July 1983 (43+ years old) and is registered under CIN U24239MH1983PTC030495.
Nisha Pharmaceuticals reported revenue of ₹4.86 Lakh for FY 2025 (up 313% YoY).
Nisha Pharmaceuticals has 3 current directors:
- Nili Jagat Shah - Director
- Shaili Jagat Shah - Director
- Nisha Jagat Shah - Director
Nisha Pharmaceuticals reported a net loss of ₹4.84 Lakh (net margin -99.6%) and EBITDA of -₹3.43 Lakh (EBITDA margin -70.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nisha Pharmaceuticals is 16% over three years. In the latest year (FY 2025) revenue rose 313%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Nisha Pharmaceuticals is U24239MH1983PTC030495. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nisha Pharmaceuticals was incorporated on 26 July 1983, making it 43+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Nisha Pharmaceuticals by revenue are Anjumankhuddamul Mutual Benefit Nidhi Limited, Fosto Pharmaceuticals Private Limited, Drugsmith Pharmaceuticals Private Limited, D V Exports Private Limited, Virat Finlease and Securities Private Limited and 5 more, all in the BFSI industry (Other Financial Services, Pharmaceuticals).
Nili Jagat Shah ceased to be Additional Director on 28 Sep 2018. Shaili Jagat Shah ceased to be Additional Director on 28 Sep 2018. Jagat Pravin Shah ceased to be Director on 19 Feb 2018. Nisha Pharmaceuticals has 6 board changes on record in total.
The registered office of Nisha Pharmaceuticals is at Das Chamberrs 4th Floor 25 Dalal Street Fort, Mumbai, Maharashtra, India – 400001.
Nisha Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.